At a glance
We’re excited to connect with you at this conference.
Meet the Afirma team and learn how Afirma GSC helps guide confident treatment decisions for thyroid nodules.
Product Theatre
| Title | Date | Time | Location | Presenters |
|---|
Afirma Molecular Testing:
Unique Situations and New Prognostic Development | Sunday, June 14 | 2:30 – 3:30 PM CT | Exhibit Hall Theater #1 | – Athanasios Bikas, M.D., Ph.D.
– Theodora Pappa, M.D., Ph.D.
(Brigham and Women’s Hospital)
– Joshua Klopper, M.D.
(Medical Director of Endocrinology, Veracyte) |
Featured Presentations & Posters
| Title | Session | Date | Time |
|---|
Association of Sodium Iodide Symporter (NIS) Expression with 2025 ATA Guidelines Estimated Risk of Structural Recurrence | Oral | Saturday, June 13 | 2:15 – 2:30 PM CT |
Preoperative Risk Stratification of Differentiated Thyroid Carcinoma Using a Molecular Cell Cycle Progression Score: Association with ATA Risk of Recurrence | Poster | Sunday, June 14 | – |
Meet with us
Interested in connecting with our team at this event? We’d love to hear from you.
Tags
North America
Afirma Thyroid
Afirma GRID